Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Larry Norton
Affiliation
Memorial Sloan Kettering Cancer Center
ORCID
Career Start Year
1976
Papers
440
H Index
109
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37090606
Functional transcriptional signatures for tumor-type-agnostic phenotype prediction.
bioRxiv
2024
37768520
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.
Breast Cancer Res Treat
2024
37090606
Functional transcriptional signatures for tumor-type-agnostic phenotype prediction.
bioRxiv
2024
37768520
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.
Breast Cancer Res Treat
2024
36414432
Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomes.
Trends Pharmacol Sci
2023
36414432
Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomes.
Trends Pharmacol Sci
2023
38030619
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival.
Blood Cancer J
2023
37561983
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
JCO Precis Oncol
2023
37414212
New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel.
J Vasc Interv Radiol
2023
36585450
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Nat Cancer
2023
37329617
Geometric graph neural networks on multi-omics data to predict cancer survival outcomes.
Comput Biol Med
2023
37221256
International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01).
NPJ Breast Cancer
2023
36843667
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management.
Ann Glob Health
2023
37561983
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
JCO Precis Oncol
2023
38030619
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival.
Blood Cancer J
2023
37221256
International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01).
NPJ Breast Cancer
2023
37414212
New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel.
J Vasc Interv Radiol
2023
37329617
Geometric graph neural networks on multi-omics data to predict cancer survival outcomes.
Comput Biol Med
2023
36585450
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Nat Cancer
2023
36843667
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management.
Ann Glob Health
2023
34599282
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Mod Pathol
2022
35902432
Escalating de-escalation in breast cancer treatment.
Breast Cancer Res Treat
2022
35953528
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.
NPJ Breast Cancer
2022
35440655
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases.
NPJ Breast Cancer
2022
35319017
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.
NPJ Breast Cancer
2022
35064104
Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program.
NPJ Breast Cancer
2022
35193955
Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.
Proc Natl Acad Sci U S A
2022
34599282
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Mod Pathol
2022
35177701
Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.
NPJ Breast Cancer
2022
35440655
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases.
NPJ Breast Cancer
2022
35902432
Escalating de-escalation in breast cancer treatment.
Breast Cancer Res Treat
2022
35953528
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.
NPJ Breast Cancer
2022
35319017
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.
NPJ Breast Cancer
2022
35177701
Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.
NPJ Breast Cancer
2022
35064104
Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program.
NPJ Breast Cancer
2022
35193955
Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.
Proc Natl Acad Sci U S A
2022
33021035
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
Mol Oncol
2021
34294707
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma.
NPJ Breast Cancer
2021
34117028
In Memoriam: José Baselga's Journey in Cancer Medicine.
Clin Cancer Res
2021
33449096
Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.
JAMA Netw Open
2021
34031428
Anti-tumor effects of an ID antagonist with no observed acquired resistance.
NPJ Breast Cancer
2021
33863915
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.
NPJ Breast Cancer
2021
33021035
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
Mol Oncol
2021
33332193
Comparative Effectiveness Research Needs to Consider Optimal Dosing and Scheduling.
J Clin Oncol
2021
34819508
Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors.
NPJ Genom Med
2021
34645798
Clonal hematopoiesis is associated with risk of severe Covid-19.
Nat Commun
2021
34416159
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.
Lancet Oncol
2021
33863915
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.
NPJ Breast Cancer
2021
34645798
Clonal hematopoiesis is associated with risk of severe Covid-19.
Nat Commun
2021
34819508
Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors.
NPJ Genom Med
2021
1 - 50 of 880
Column Actions
Search
Recommended Authors
Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year
2015
Number of shared co-authors
19
Konstantinos Tryfonidis
Merck & Co., Inc.
Career Start Year
2011
Number of shared co-authors
8
Carmen Criscitiello
University of Milano
Career Start Year
2008
Number of shared co-authors
6
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
6
Sharon F McGee
The Ottawa Hospital Cancer Centre
Career Start Year
2006
Number of shared co-authors
0
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year
2006
Number of shared co-authors
10
Sara M Tolaney
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
17
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year
2004
Number of shared co-authors
20
David W Cescon
Princess Margaret Cancer Centre
Career Start Year
2003
Number of shared co-authors
9
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
27
Matthew P Goetz
Mayo Clinic
Career Start Year
2002
Number of shared co-authors
24
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year
2000
Number of shared co-authors
20
Eleni Andreopoulou
New York Presbyterian Hospital
Career Start Year
1997
Number of shared co-authors
8
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year
1995
Number of shared co-authors
14
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Career Start Year
1995
Number of shared co-authors
6
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1994
Number of shared co-authors
2
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year
1993
Number of shared co-authors
8
Vera J Suman
Mayo Clinic
Career Start Year
1992
Number of shared co-authors
17
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year
1992
Number of shared co-authors
11
Ramona F Swaby
Merck & Co., Inc.
Career Start Year
1991
Number of shared co-authors
5
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year
1990
Number of shared co-authors
27
Caroline Seynaeve
Erasmus Medical Center
Career Start Year
1990
Number of shared co-authors
22
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Career Start Year
1989
Number of shared co-authors
3
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year
1988
Number of shared co-authors
13
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year
1987
Number of shared co-authors
3
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year
1987
Number of shared co-authors
8
Chris Twelves
Leeds Teaching Hospitals NHS Trust, University of Leeds
Career Start Year
1986
Number of shared co-authors
7
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year
1986
Number of shared co-authors
10
Stefan Aebi
University of Bern
Career Start Year
1985
Number of shared co-authors
7
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Career Start Year
1984
Number of shared co-authors
13
row(s) 1 - 30 of 30
Collaborators
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers
139
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
44
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers
40
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers
36
Eric P Winer
Dana-Farber Cancer Institute
Co-authored papers
34
Donald A Berry
MD Anderson Cancer Center
Co-authored papers
31
José Baselga
Co-authored papers
28
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Co-authored papers
26
Charlotte K Y Ng
University of Bern
Co-authored papers
25
Salvatore Piscuoglio
University of Basel
Co-authored papers
24
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers
18
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers
15
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers
15
Luciano G Martelotto
Monash University
Co-authored papers
12
Tari A King
Co-authored papers
12
James N Ingle
Mayo Clinic
Co-authored papers
11
Ronglai Shen
Co-authored papers
10
Ian E Krop
Co-authored papers
10
Mark M Moasser
Helen Diller Family Comprehensive Cancer Center
Co-authored papers
10
Michael F Berger
Co-authored papers
9
Nancy E Davidson
Co-authored papers
9
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers
9
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers
9
Kathleen A Burke
Brown University
Co-authored papers
9
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Co-authored papers
9
Lisa A Carey
Co-authored papers
9
Nancy U Lin
Co-authored papers
8
Lynn G Dressler
Duke University Research Institute
Co-authored papers
7
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers
7
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers
7
1 - 30